Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

NCT00545766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Vinflunine

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]